Most of veterinary medicines are natural products and they can be directly used as medicine. The majority of Chinese medicines need simple processing and concocted medicine, such as wolfberry, rhizome and black snake. Traditional veterinary drugs in compound or single-flavor powder mostly use the original product as bulk drugs. For example, pulsatilla, copts, phellodendron, orange peel and rhubarb need to be made of single-flavor powder. The clinical application of the extract composition increases palatability and improves the efficacy including compound, single herb. They all contain all Chinese herbal medicine active ingredients. The medicines ingredients are not clear, and the related products belong to third-category drugs.
At present, China has more than 600 Chinese herbal medicine production bases in planting area of 1,800 acre and 2000 acre; 600 kinds of commonly used herbs, and extensive cultivation of over 400 kinds, the annual output of 300,000 tons, accounting for about 70% of the supply; than 400 kinds of wild Chinese herbal medicines, the annual output of 400,000 tons. Traditional Chinese medicine resources are approximately 12 807 species. There are 7000 kinds of folk medicine (herbal medicine) AND 4000 kinds of folk medicines.
The main factors that influencing veterinary pharmaceutical raw materials’ quality are the low level of modernization of Chinese medicine, the lack of standards, inspection and supervision system and institutions are not perfect. In planting and breeding area of a wider area under cultivation of different sizes, the heterogeneity of production and business conditions significantly affect the growth environment and growth habit of the performance of Chinese herbal medicines. Residues of pesticides, fertilizers, excessive, excessive heavy metals, light the lack of time resulting in potency to change, increase in drug toxicity.
In veterinary medicine is one of the future animal disease prevention, treatment and care of the preferred drug. Modernization of veterinary medicine in veterinary medicine the golden key to open the international market. Improve the veterinary raw materials in drug production and processing technologies, to develop a standardized system for standardization of clinical treatment, to ensure the clinical safety of medication. Accelerate innovative research and development of veterinary drugs in pharmaceutical raw materials and conversion of the pace of domestic and international market competitiveness enhanced in veterinary medicine.
China should speed up the traditional Chinese medicine cultivation techniques to optimize the traditional Chinese medicine seed cultivation, optimization of planting base of the surrounding environment, the development of Chinese herbal medicines ecological planting and breeding model, the use of biotechnology to develop new ideas of Chinese docetaxel medicine cultivation. China needs to carry out the study of veterinary pharmaceutical raw materials and improve the biological control of Chinese herbal medicine diseases and insect pests.
Wild medicinal plant species in China reached more than 10,000 kinds. They have a broader application and a significant effect. But it lacks of standards and can not get the recognition and promotion. The average well-known international pharmaceutical companies come up with more than 20% of profits each year for scientific research. The majority of enterprises paid insufficient attention to research and development investments. In China, there only more than 500 species of plants which has a more systematic study. There are more than 100 kinds of medicinal plants are found. But the United States and other countries invest a lot of money for research and development of wild medicinal plants each year.
Source:http://www.cospcn.com
没有评论:
发表评论